If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Arix Bioscience, Russ Mould on the Fed & Paul Hill on Boohoo
Jonathan Tobin Managing Director Arix Bioscience (ARIX) discusses one of their portfolio company's Atox Bio which plans a new drug application submission for Q3.
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Russ Mould, Investment Director at stockbroker AJ Bell talks about the FED and their influence on the market.
(Interview starts at 14 minutes 52 seconds)
Paul Hill, full time investor and equity analyst gives his view on:
Boohoo (BOO)
Rosslyn Data Technologies (RDT)
(Interview starts at 25 minutes 50 seconds)